JOSE EMILIO S.
MORA BERMUDEZ
Investigador no período 1992-2019
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (10)
2020
-
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
International Journal of Infectious Diseases, Vol. 101, pp. 290-297
-
Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis
PLoS ONE, Vol. 15, Núm. 12 December
-
Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia: Risk factors and endoscopic findings
Journal of Clinical Medicine, Vol. 9, Núm. 1
-
Gender differences in hereditary hemorrhagic telangiectasia severity
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Letter to the Editor: mTOR-Inhibitor-Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia
Hepatology
-
Usefulness of systolic blood pressure combined with heart rate measured on admission to identify 1-year all-cause mortality risk in elderly patients firstly hospitalized due to acute heart failure
Aging Clinical and Experimental Research, Vol. 32, Núm. 1, pp. 99-106
2019
-
PI3K (phosphatidylinositol 3-kinase) activation and endothelial cell proliferation in patients with hemorrhagic hereditary telangiectasia type 1
Cells, Vol. 8, Núm. 9
-
Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study)
Archives of Orthopaedic and Trauma Surgery, Vol. 139, Núm. 5, pp. 597-604
2013
-
Predictors of cognitive decline in 85-year-old patients without cognitive impairment at baseline: 2-year follow-up of the Octabaix study
American Journal of Alzheimer's Disease and other Dementias, Vol. 28, Núm. 2, pp. 147-153